Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated May 11, 2017 (9 years ago)

Oxygen Refrigerated Liquid USP UN 1073

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

GMP Deviations: The firm does not include an SOP for testing for out of specifications.

Cause type: Failed specification

A physical or chemical test other than potency, dissolution, impurity or stability failed - pH, viscosity, appearance, tablet integrity, fill volume. A product outside its own specification may not perform as designed, even if the active ingredient is present. All failed specification recalls.

What was recalled

Oxygen Refrigerated Liquid USP UN 1073, Rx only, At Home Medical 200 American Road, Morris Plains, NJ 07950,973-538-0485.

Recalling firm
AtHome Medical, Inc.
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1060-2017 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other failed specification recalls from 2017

All failed specification recalls
Class II · Moderate risk

Valsartan Tablets

Failed Tablet/Capsule Specifications: confirmed customer complaint of thicker and heavier tablets in bottle.

Terminated Failed specification Prinston Pharmaceutical Inc NDC 43547-369-09 D-0209-2018
Class II · Moderate risk

Vertra Elemental Resistance

CGMP Deviations: products manufactured in a manner that may impact product quality that includes but is not limited to failed viscosity.

Terminated Failed specification Eai-Jr286 INC D-0100-2018
Class II · Moderate risk

Clozapine Tablets USP

Failed Tablet/Capsule Specifications; potential presence of broken tablets.

Terminated Failed specification Teva Pharmaceuticals USA NDC 00093-7772-05 D-0096-2018